Overview
Cyril Flamant practices in Nantes, France. Mr. Flamant is rated as a Distinguished expert by MediFind in the treatment of Premature Infant. His top areas of expertise are Premature Infant, Patent Ductus Arteriosus, Infant Respiratory Distress Syndrome, and Intrauterine Growth Restriction.
His clinical research consists of co-authoring 94 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 61 articles in the study of Premature Infant.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Premature InfantMr. Flamant isDistinguished. Learn about Premature Infant.
- Advanced
- Infant Respiratory Distress Syndrome
- Patent Ductus ArteriosusMr. Flamant isAdvanced. Learn about Patent Ductus Arteriosus.
- Experienced
- Acute Kidney FailureMr. Flamant isExperienced. Learn about Acute Kidney Failure.
- Bronchopulmonary DysplasiaMr. Flamant isExperienced. Learn about Bronchopulmonary Dysplasia.
- Cerebral PalsyMr. Flamant isExperienced. Learn about Cerebral Palsy.
- High Blood Pressure in InfantsMr. Flamant isExperienced. Learn about High Blood Pressure in Infants.
- Infant HyperglycemiaMr. Flamant isExperienced. Learn about Infant Hyperglycemia.
- Intrauterine Growth RestrictionMr. Flamant isExperienced. Learn about Intrauterine Growth Restriction.